IP Verse

Scalable Lentiviral Vector Production System Compatible With Industrial Pharmaceutical Applications

EP2782997

GENETHON
Application Number
EP12795778A
Filing Date
Nov 26, 2012
Status
Revoked
May 20, 2022
Grant Date
Jan 10, 2018
External Links
Slate, Register

Biblio Summary

The patent EP2782997B1 was granted on Jan 10, 2018 by Genethon The patent is currently Revoked.

Oppositions Filed by other Companies on the Patent

The table below shows 8 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HOFFMANN EITLEOct 10, 2018ADMISSIBLE
JAMES POOLE LIMITEDOct 10, 2018ADMISSIBLE
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBBOct 10, 2018ADMISSIBLE
RICKER, MATHIASOct 10, 2018ADMISSIBLE
STRAWMAN LIMITEDOct 10, 2018ADMISSIBLE
MILTENYI BIOTEC GMBHOct 9, 2018ADMISSIBLE
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITEDOct 4, 2018ADMISSIBLE
OXFORD BIOMEDICA (UK) LIMITEDOct 4, 2018ADMISSIBLE

More Opposed Patents of Genethon

The table below shows the patents of Genethon that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3083970Method For Purifying Enveloped Viruses Or Viral VectorsMar 13, 20242
EP3768304Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing ImmunoglobulinsOct 12, 20226
EP3505635Widespread Gene Delivery To Motor Neurons Using Peripheral Injection Of Aav VectorsMay 18, 20221

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents